NASDAQ

Mineralys Therapeutics, Inc. (MLYS)

♥ 638 Thanks from members

Live price chart, market sentiment, and community perspectives for Mineralys Therapeutics, Inc. (NASDAQ: MLYS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Orin HerskowitzFounder: Venture founders from Columbia University researchLeadership: David Hastings (CEO)Leadership: Dr. Bhaskar Chaudhuri (Chief Medical Officer)Holder: Bain Capital Life SciencesHolder: RA Capital ManagementHolder: RTW InvestmentsBaxdrostatAldosterone synthase inhibitorsCardiovascular therapeutics pipeline#MLYS stock#Mineralys Therapeutics#NASDAQ MLYS#Baxdrostat#cardiovascular biotech